No safety problem on drugs containing poison and deleterious substances.

Published: 2004-09-07 06:56:00

Updated: 2004-09-07 06:56:00

In responding to the recent controversy raised by the press over the safety problems on the non-prescription GI drug containing a poisonous and deleterious ingredient the MOHW confirmed no safety problems at all since its classification was determined by the expert groups after thorough reviews.
...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK